India to Mexico: Trastuzumab Export Trade Route

The India to Mexico Trastuzumab corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $2.7M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $907.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 18.4%, placing it at rank #17 among India's top trastuzumab export destinations globally.

On the import side, key buyers of Indian trastuzumab in Mexico include ZYDUS PHARMACEUTICALS M?XICO S.A. D. ZYDUS PHARMACEUTICALS M?XICO S.A. D is the single largest importer with 3 shipments valued at $2.7M USD.

India's trastuzumab exports to Mexico are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $907.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, ZYDUS PHARMACEUTICALS M?XICO S.A. D is the largest importer with 3 shipments worth $2.7M USD — representing 100% of all trastuzumab imports from India on this route.